Background: The overall aim of this study was to describe trends in participation rates and detection of lesions in a colorectal cancer (CRC) screening programme, during three rounds, using faecal immunochemical test (FIT). Methods: National registers were used to collect data on invitations for CRC screening in the Basque Country (Spain) from 2009 to 2014. Information about participation, age, gender and lesions in each round were collected. Results: A total of 961.533 individuals were included in the analysis; respectively, 584.950, 298.143 and 78.440 in the first, second and third rounds. The average participation rate was 68.4% (66.8, 70.4 and 72.3%, respectively by round; P < 0.001) and the positivity rate was 6.3% (7, 5.5 and 5.4%, respectively by round; P < 0.001). The participation rate increased significantly with age and was found to be higher in women versus men. A total of 15.144 advanced adenomas and 2.131 CRCs were diagnosed, leading to a detection rate of 23.9 and 3.4ø, respectively. Regarding gender, men had the highest rates in all periods and rounds. The detection rate of advanced neoplasia was lower in the regular when compared with irregular paricipants. Conclusions: In a CRC screening, this organization obtained high FIT participation rates. Older participants and women were associated with a higher participation. The detection rate of lesions was higher in men, independent on age and round.
Introduction
A mong all the countries within the European region, the incidence of colorectal cancer (CRC) in Spain occupies an intermediate position. In 2012, 19 261 and 12 979 new cases were estimated in men (43.9 Age Standardized incidence Rates-ASRi) and women (17.1 ASRi), respectively, accounting for 8742 deaths in men (17.1 ASRi) and 5958 in women (8.4 ASRi) for the same period. 1 CRC screening has proven to be a cost effective strategy to reduce mortality and long-term incidence, regardless of the used diagnostic method, such as faecal occult blood testing (FOBT), colonoscopy or sigmoidoscopy. 2, 3 Within the FOBT screening method, significant variations have been found in the characteristics of the programmes and in the invitation processes. 4 Organized programmes, which include: (i) a process of individualized invitation; (ii) a control and predefined results monitoring criteria and; (iii) established process quality indicators are those recommended by the European Guidelines in CRC screening and diagnosis. 5 Participation in screening programmes is one of the essential parameters to maximize their impact. Controlled studies on different strategies and costs have shown that small increases in participation can generate significant differences in their impact. 6 Moreover, the urgent need to detect a greater number of advanced lesions, known as adenomas and advanced adenomas (AAs), has pointed that screening methods, such as traditional guaiac FOBT (gFOBT), are obsolete. Consequently, they are being gradually replaced by faecal immunochemical tests (FITs) considering that these type of testes are far more acceptable by participants and more effective in lesions detection. 7, 8 In a meta-analysis, FIT was shown to be superior than gFOBT, in terms of sensitivity and specificity. 9 To achieve high coverage and participation, access to the screening test and subsequent treatments are the main challenges for organized programmes. Proper, management will result in higher overall benefit and greater impact measured in terms of efficiency. 10 The aim of this study was then to describe the participation and results after three consecutive invitation in a population-based CRC screening programme.
Methods

Study population and interventions
The Basque Country CRC Screening Programme is a populationbased programme initiat in 2009 as a pilot project, being extended and consolidated in 2010 after evaluation and optimization of the processes. The biennial screening is based on the detection of occult blood in faeces using a quantitative FIT, targeting women and men between 50 and 69 years of age (both included) and a colonoscopy under sedation for FIT positive cases. We identified all subjects invited from 1 January 2009 to 31 December 2014, whose invitations were valid and had participated in the first, second and/or third round. We obtained quality indicators and also data about age, gender and screening rounds.
The main strategy was based on: (i) Coordinating Office, including clinical epidemiologists and statisticians was responsible for planning, organization and managing; (ii) Invitation letters to all residents from 50 to 69 years (both included) assigning them to Health Care Centres and referral Hospitals taking into account expected positivity rate and colonoscopy capacity; (iii) Target population selection by the Coordinating Office, prior to the invitation. The selected ones were identified in the database of the Basque Population Cancer and Medical Procedures Registries in order to exclude people with a previously diagnosed CRC, terminal illness and reported sigmoidoscopy or colonoscopy within the previous 5 years or if they had symptoms requiring additional workup; (iv) Training and involvement of Basque Health Service staff; (v) Individualized posted invitations providing information about the programme. A 4-6 weeks after initial invitation, the kit was sent along with instructions and an individualized barcode. This barcode allowed the sample and person to be identified when processing the result. Samples were collected at Primary Health Centres of the Basque Public Health Service and processed in centralized public laboratories under strict quality management systems; (vi) All results were reviewed by Primary Care Physicians and introduced in the ''ad hoc'' CRC software. Letters were posted with the results: (a) if negative, the invitation will occur two years later for participants younger than 70 years, or (b) if positive, participants were recommended to visit their Primary Care Physician, who prescribes colonoscopy and (c) in case of an error in reading the kit, another kit and instructions were sent; (vii) All cases were followed-up closely between Primary Care and Specialized Units; (viii) Every case was coded by the Coordinating Office staff following standard EU guidelines and Spanish Network consensus recommendations.
11,12
Definitions
The FIT used was OC-Sensor Micro (Eiken Chemical Co. Ltd., Tokyo, Japan). OC-Sensor is a quantitative FIT, with chemistry based on human haemoglobin antibody mediated latex agglutination. Barcoded specimen were analysed for f-Hb by collection devices. The result was considered positive when faecal-haemoglobin (f-Hb) was !20 mg Hb/g faeces.
All colonoscopies were performed by experienced endoscopists (performing >200 colonoscopies per year). Colonoscopy quality was ensured by following the Spanish Gastroenterological Association and Spanish Society for Digestive Endoscopy guidelines. 13 The histology of all lesions was evaluated by expert pathologists specialized in gastrointestinal oncology according to the quality standards. The maximum reach of the colonoscope, bowel preparation quality, as well as the characteristics and location of any polyps were recorded. Adenomas !10 mm, !3 adenoma, adenoma with a villous component (i.e. tubulovillous or villous adenoma) or adenomas with severe/high-grade dysplasia were classified as advanced adenomas (AA). The remaining adenomas were defined as non-AAs or low-risk adenomas (LRAs). Advanced neoplasia (AN) was defined as CRC plus AA. Cancer staging was established according to the TNM classification system in agreement with the AJCC Cancer Staging Manual and stages I and II were defined as early stages.
14 Finally, participants were classified and then assigned to a group according to the most advanced lesion. The location was classified as proximal or distal, with proximal indicating that the cancer lay between the caecum and the splenic flexure, and distal indicating that it lay between the splenic flexure and the anus. Individuals who participated in less number of rounds that they had been invited were considered irregulars. Likewise, the individuals who participated in all invited rounds were defined as regular participants.
This study was approved by the Basque Country Ethics Committee (January 2009). The study protocol was according to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a prior approval by the institution's human research committee. All participants provide written informed consent.
Data analysis
Categorical variables were described using frequencies, percentages and continuous variables by mean and standard and/or median and interquartile range depending on the distributional deviation characteristics. The comparison between categorical variables was performed using the chi-square test or Fisher's exact test.
Rates and incidence rate ratios were estimated using Poisson regression models. These were calculated for the overall population and by gender, age and rounds included in the model, in order to estimate trends over time.
We used multivariate logistic regression to estimate the detection rate of lesions by gender and age group. We considered a P values <0.05 to determine statistical significance. Finally, CIs were considered 95% in all cases.
All statistical analyses were performed using SPSS 22.0 and STATA 13.
Results
Participation
The total eligible population included 961.533 people with a valid invitation occurring in 96.1% (95% CI 96.1-96.2) of all the cases. The average participation rate was 68.4% (95% CI 68.3-68.5), with a positive rate of 6.3% (95% CI 6.3-6.4) and an acceptance rate for colonoscopy of 92.9% (95% CI 92.7-93.2). Table 1 indicates distribution by gender, age group and round, highlighting the greater participation in women. Higher positivity and detection rates were observed in men and within the most advanced age group (P < 0.0001). As shown in Supplementary figure S1, participation rate revealed an increasing trend over the invitation years and rounds, with a similar pattern in both genders, although superior in women (P < 0.0001).
The participation rate increased significantly in the first screening round during the invitation period (2009-14) for all age groups, consistently between 2.2% and 3.1% annually (table 2). The biggest increase was observed in the 50-to 54-year old-group and the smallest in the group of 60-64 years. Noteworthy, the participation rate presented a reverse U-shaped distribution among all age groups. In the second screening round, there was also a significant increase in participation for all age groups also following an inverted U-shape distribution and an annual increase between 1.1 and 1.7%. In the third screening round, the participation rate followed and increase trend reaching 74.8%.
Regarding positive testing, an average of 7.0% (95% CI 6.8-7.0) was found in the first round decreasing to 5.5% (95% CI 5.4-5, 6) (table 3) . A gender analysis showed a significant increase for both genders, in first and second round but a significant decline in the third screening round. The rate of diagnostic colonoscopies performed after a positive result stood at 93.5, 91.4 and 93.5% in the first, second and third round, respectively (table 3) , and no significant differences between genders were observed.
Detection rates
A total of 15.144 AA and 2.131 CRC were detected, representing a total of 17.275 AN, with a detection rate of 23.9ø (95% CI 23.6-24.3), 3.4ø (95% CI 3.2-3.5) and 27.3ø (95% CI 26.9-27.7), respectively. Regarding the stage in which they were detected, 66.3% (95% CI 64.3-68.3) were diagnosed at early stages (I and II) (table 3) .
When lesions were detected, a downward trend was observed in AA, CRC and AN during the first round since 2013, in which new participants in the programme were mainly within the 50-54 years age group. There is a need to highlight the difference observed among men and women, as men being those who had higher detection rates in all age groups and screening rounds. In Supplementary figure S2, significant differences can be observed, featuring an important increase of 1.066 (95% CI 1.002-1.135) of AAs in women during the second round and a decrease of CRC and AA of 0.877 (95% CI 0.780-0.986) and 0.762 (95% CI 0.634-0.914), respectively, in men throughout the third round. AA detection rate increased significantly in the first round for all except the 50-54 age group, with an annual increase ranging from 3.1 to 3.3%. In the second round, the same trend was evident, being the annual increase even bigger, between 7.8 and 9.4%. CRC detection rate raised without reaching statistical significance in first and second round for all age groups except for 65-69 years group in the second round (table 4) .
The risk of detecting a lesion was greater in male compared with female and this risk was even higher for AN, in which it was doubled when compared with LRA. We observed that the risk increases with age considering malignant and premalignant lesions (Supplementary figure S2B) .
Regarding to positive predictive value, a variation between different rounds was observed, with 46.4% (95% CI 45.8-47.8) for AN in first, 36.6% (95% CI 35.7-37.5) in second and 37.3% (95% CI 37.3-38.2) in third round (table 3) . Moreover, differences between men and women were maintained (table 1) .
Relationship between participation and detection
Supplementary table S1 shows the observed distribution by gender and age groups according to the pattern of participation. Participation was higher in women than men in the first screening round and regular participants. Regarding age groups, a similar distribution between regular and irregular participants was observed. Concerning detection rates, we observed lower rates in regular participants, specifically in both CRC and adenomas. Similar distribution of detected lesions percentages by stage was observed, both from first round and irregular participants.
Regarding to CRC localization, distal colon was the most frequent location during the first round (75%) and irregular participants (77.8%), and it was 66.5% in the case of regular participants (Supplementary table S1 ).
Discussion
One of the main successful factors in screening programmes and reducing CRC mortality is to achieve high participation. A participation rate of more than 50% is recommended. The participation rate in this particular screening programme with FIT was very high (68.4%) and participation has been increasing significantly since 2009. It is well known that when a own physician recommends the patients to participate in a screening programme, this participation rate consequently increase significantly (men OR 5.0 and women OR 3.8). 15, 16 Participation also increased when the kit is delivered directly to participants home or delivered for the primary care physician. 17 A meta-analysis evaluating the participation rates in screening programmes concluded that measures such as sending invitation letters, delivering kits and decreasing barriers improve the participation. 18 In our study, among the factors that could have facilitated the high participation include delivering the kit to the participants home, a reminder letter and a physician's recommendation. Other implemented measures that probably have influenced these results are: developing a centralized database and a unique Coordinator Office managing the process, empowerment and participation at all levels of primary care centres and professionals, and finally, colonoscopy with sedation in all cases. A better understanding of these factors could be improved using a multilevel methodology that also provides clues to improve adherence to the programmes. 18, 19 As observed in previous studies [20] [21] [22] the participation was greater in older individuals, in women and in second and third screening round. These observations may be due to a greater awareness of the screening programme and its benefits by the population and professionals. The results of the screening programme have been public available and reported since the very beginning of it and they have been part of the training offered to professionals, according to the recommendations made in the European Guidelines on effective communication and organization of the programme in order to maintain a high level of quality in the process. 11 Furthermore, participation also increased in all age groups and in all three rounds. Noteworthy, attention should also be focussed on the younger participants in the first round as this group tends to reduce participation and are possibly the age group that could potentially obtain the greatest benefit from the long-term programme. Bigger effort is required to encourage attendance in this age group.
We have reported a higher positivity rate (6, 3%) with the same cut-off point (>20 mg Hb/g faeces) than in previously published studies with the same test as reflected in the recommendations of the European Guidelines. 12 It is also worth noting that although the positivity rate is constantly significantly higher in men (8.1% men vs. 4.8% woman), it tends to decrease significantly in subsequent invitations which could be related to different behaviour of FIT in women, as outlined in other studies. 23, 24 Thus, the lower FIT positivity rate in women may be due to a lower incidence of colorectal neoplasia, or to other factors such as increased use of nonsteroidal anti-inflammatory drugs and low-dose aspirin in men, a lower f-Hb concentration lower in woman or a slower colonic transit in women compared with men. In the latest scenario, the f-Hb could be very unstable being degraded in the gut before the excretion of faeces. The pattern of participation and AN detection was similar between participants invited for the first time and irregular participants. When CRC detection was evaluated according to the pattern of participation, the age increased in regular participation with a similar pattern in the CRC stages.
Regarding the rate of adherence to screening colonoscopy in all rounds, our results demonstrated higher rate compared with data described by European Guidelines and most of previously published studies which barely exceeded 90%. 11, 25 These high rate might be related to the organization of the screening programme, the monitoring of all positive cases, the previous consultations with Primary Care Nurses and Physicians, the availability of written and audiovisual materials availability and colonoscopies performed under deep sedation. The lesion detection rate analysis reported a high trend in the first round with a significant decrease in successive rounds, following the same pattern of the positive test. It is worth saying that the largest decline occurred mainly in men. This trend has been observed in other studies concerning screening programme with repeated FIT testing. 26 Nevertheless, more detailed qualitative and quantitative studies would be required to assess these effects.
The screening programme of the Basque Country could expect a high impact on CRC mortality due to its rapid extension, high participation, high acceptance of the colonoscopy in the positive cases and high detection rate of AA and CRC in early stages (66.3% stages I and II). The high attendance in the screening programme and detection of AN is essential to reduce the mortality by CRC as it has been observed in other studies with a mortality reduction of 13% in men and 36% in women. 27 In summary, the creation of a CRC screening programme based on sending FIT to the participant's home, the implication of primary care and the colonoscopy with sedation obtain a high participation. Older and female participant were associated with a higher participation rates and this effect was increased in successive rounds of screening.
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